NKT Therapeutics' Identifies Novel anti-iNKT Antibodies for Depleting or ... PR Newswire (press release) WALTHAM, Mass., Dec. 9, 2013 /PRNewswire/ -- NKT Therapeutics (NKTT) today presented research results with NKT14 and NKT14m, monoclonal antibodies designed to deplete (NKT14) or activate (NKT14m) murine iNKT cells. The results from these ... |
